Cite

HARVARD Citation

    Weng, G. et al. (2023). Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia. Journal of internal medicine. pp. 329-339. [Online]. 
  
Back to record